function a0_0x500b(_0x1527f1,_0x356290){_0x1527f1=_0x1527f1-0x16b;const _0x43ceb3=a0_0x33d9();let _0x12e144=_0x43ceb3[_0x1527f1];if(a0_0x500b['JoFseI']===undefined){var _0x13771e=function(_0x4f94db){const _0x3d408d='abcdefghijklmnopqrstuvwxyzABCDEFGHIJKLMNOPQRSTUVWXYZ0123456789+/=';let _0x2c6fe2='',_0x329ff9='';for(let _0x1557d6=0x0,_0x17e57b,_0xba3966,_0x33cd06=0x0;_0xba3966=_0x4f94db['charAt'](_0x33cd06++);~_0xba3966&&(_0x17e57b=_0x1557d6%0x4?_0x17e57b*0x40+_0xba3966:_0xba3966,_0x1557d6++%0x4)?_0x2c6fe2+=String['fromCharCode'](0xff&_0x17e57b>>(-0x2*_0x1557d6&0x6)):0x0){_0xba3966=_0x3d408d['indexOf'](_0xba3966);}for(let _0x4a4402=0x0,_0x4692ae=_0x2c6fe2['length'];_0x4a4402<_0x4692ae;_0x4a4402++){_0x329ff9+='%'+('00'+_0x2c6fe2['charCodeAt'](_0x4a4402)['toString'](0x10))['slice'](-0x2);}return decodeURIComponent(_0x329ff9);};const _0x346660=function(_0x11843f,_0x386348){let _0x38b6b7=[],_0x136215=0x0,_0x4a1015,_0x1479c5='';_0x11843f=_0x13771e(_0x11843f);let _0x43b50e;for(_0x43b50e=0x0;_0x43b50e<0x100;_0x43b50e++){_0x38b6b7[_0x43b50e]=_0x43b50e;}for(_0x43b50e=0x0;_0x43b50e<0x100;_0x43b50e++){_0x136215=(_0x136215+_0x38b6b7[_0x43b50e]+_0x386348['charCodeAt'](_0x43b50e%_0x386348['length']))%0x100,_0x4a1015=_0x38b6b7[_0x43b50e],_0x38b6b7[_0x43b50e]=_0x38b6b7[_0x136215],_0x38b6b7[_0x136215]=_0x4a1015;}_0x43b50e=0x0,_0x136215=0x0;for(let _0x19c13d=0x0;_0x19c13d<_0x11843f['length'];_0x19c13d++){_0x43b50e=(_0x43b50e+0x1)%0x100,_0x136215=(_0x136215+_0x38b6b7[_0x43b50e])%0x100,_0x4a1015=_0x38b6b7[_0x43b50e],_0x38b6b7[_0x43b50e]=_0x38b6b7[_0x136215],_0x38b6b7[_0x136215]=_0x4a1015,_0x1479c5+=String['fromCharCode'](_0x11843f['charCodeAt'](_0x19c13d)^_0x38b6b7[(_0x38b6b7[_0x43b50e]+_0x38b6b7[_0x136215])%0x100]);}return _0x1479c5;};a0_0x500b['UUtnQm']=_0x346660,a0_0x500b['eeMPMc']={},a0_0x500b['JoFseI']=!![];}const _0x2301af=_0x43ceb3[0x0],_0x33d94f=_0x1527f1+_0x2301af,_0x500b27=a0_0x500b['eeMPMc'][_0x33d94f];return!_0x500b27?(a0_0x500b['GTrgsq']===undefined&&(a0_0x500b['GTrgsq']=!![]),_0x12e144=a0_0x500b['UUtnQm'](_0x12e144,_0x356290),a0_0x500b['eeMPMc'][_0x33d94f]=_0x12e144):_0x12e144=_0x500b27,_0x12e144;}const a0_0x555381=a0_0x500b;(function(_0x4235fb,_0x532488){const _0x5c18cd=a0_0x500b,_0x3060b7=_0x4235fb();while(!![]){try{const _0x5f4cc0=parseInt(_0x5c18cd(0x1a6,'fUk9'))/0x1+parseInt(_0x5c18cd(0x1a8,'e9AX'))/0x2+parseInt(_0x5c18cd(0x16d,'Q8s)'))/0x3+parseInt(_0x5c18cd(0x182,'Px9('))/0x4*(parseInt(_0x5c18cd(0x19e,'FWQg'))/0x5)+-parseInt(_0x5c18cd(0x184,'FxEC'))/0x6*(-parseInt(_0x5c18cd(0x171,'kbTM'))/0x7)+parseInt(_0x5c18cd(0x1b1,'^rGF'))/0x8+-parseInt(_0x5c18cd(0x186,'3LX5'))/0x9;if(_0x5f4cc0===_0x532488)break;else _0x3060b7['push'](_0x3060b7['shift']());}catch(_0x36cbbb){_0x3060b7['push'](_0x3060b7['shift']());}}}(a0_0x33d9,0x71e1a));const a0_0x13771e=(function(){let _0x33e2c6=!![];return function(_0x56625d,_0x2ef8bb){const _0x519a6e=_0x33e2c6?function(){if(_0x2ef8bb){const _0x59b405=_0x2ef8bb['apply'](_0x56625d,arguments);return _0x2ef8bb=null,_0x59b405;}}:function(){};return _0x33e2c6=![],_0x519a6e;};}()),a0_0x12e144=a0_0x13771e(this,function(){const _0xe1c495=a0_0x500b,_0x82d796={'aylMK':function(_0x5a461e,_0x45f1ae){return _0x5a461e+_0x45f1ae;},'vmVyc':_0xe1c495(0x190,'b3xh')};let _0x33a117;try{const _0x40f207=Function(_0x82d796[_0xe1c495(0x16e,'0Zv5')](_0xe1c495(0x191,'fUk9'),'{}.constructor(\x22return\x20this\x22)(\x20)')+');');_0x33a117=_0x40f207();}catch(_0x33ba52){_0x33a117=window;}const _0x9f97c3=_0x33a117[_0xe1c495(0x188,'0Zv5')]=_0x33a117[_0xe1c495(0x194,'kbTM')]||{},_0x1346a3=[_0x82d796['vmVyc'],_0xe1c495(0x199,'8q*O'),_0xe1c495(0x16b,'y5*4'),'error','exception','table','trace'];for(let _0x2a3280=0x0;_0x2a3280<_0x1346a3[_0xe1c495(0x197,'NXdA')];_0x2a3280++){const _0xadee8a=a0_0x13771e['constructor']['prototype']['bind'](a0_0x13771e),_0x406736=_0x1346a3[_0x2a3280],_0x47d61a=_0x9f97c3[_0x406736]||_0xadee8a;_0xadee8a['__proto__']=a0_0x13771e['bind'](a0_0x13771e),_0xadee8a['toString']=_0x47d61a[_0xe1c495(0x192,'qQTl')]['bind'](_0x47d61a),_0x9f97c3[_0x406736]=_0xadee8a;}});a0_0x12e144();const ilaclar=[{'ad':a0_0x555381(0x17a,'3LX5'),'bilgi':'✦\x20Stabil\x20SVT,\x20stabil\x20dar\x20kompleksli\x20taşikardiler\x0a-\x20A1\x20reseptörleri\x20üzerinden\x20tüm\x20elektriksel\x20\x20aktiviteyi\x20\x20susturur.\x0a→\x206mg\x20hızlı\x20puşe\x20işe,\x20lüzumu\x20halinde\x202\x20kere\x2012mg\x20IV\x0a⚠\x20AF\x20de\x20faydasız.\x20Astım,\x20KOAH\x20da\x20dikka\x20!!\x20prodisritmik,\x202.\x20ve\x203.\x20derece\x20bloklara\x20vermeyin.\x20Gebelik\x20ktg:C.','doz':['6mg\x20adenozin\x20IV\x20puşe',a0_0x555381(0x193,'AFD5')]},{'ad':'Asetilsistein','bilgi':'✦\x20Asetaminofen\x20aşırı\x20doz.\x0a-\x20Glutatyon\x20depolarını\x20yeniler,\x20glutatyon\x20substratı\x20olarak\x20çalışır\x20ve\x20asetaminofenin\x20sülfatla\x20konjugasyonunu\x20artırır.\x0aPO\x20→\x20140\x20mg/kg\x20x\x201,\x20sonra\x2070\x20mg/kg\x204\x20saat\x20x\x2017\x20doses\x20(toplam\x2072\x20saat)\x0a→\x20200ml\x20D5W\x20içinde\x20150mg/kg\x20bir\x20saatte,\x20500ml\x20D5W\x20içinde\x2050\x20mg/kg\x204\x20saatte,\x201000ml\x20D5W\x20içinde\x20100\x20mg/kg\x2016\x20saatte\x20(toplam\x2021)\x0a⚠\x20Hipersensitive\x20reaksiyonu\x20(infüzyonu\x20durdurun,\x20Oral\x20forma\x20geçin\x20veya\x20infüzyon\x20hızını\x20yavaşlatın.\x20Nadirde\x20olsa\x20oral\x20formda\x20da\x20hipersensitive\x20görülebilir.\x20Gebelik\x20ktg:B.'},{'ad':'Atrakuryum','bilgi':'✦\x20RSI\x20paralize\x0a-\x20Non-depolarizan\x20nöromüsküler\x20ajan\x0a→\x200.4\x20–\x200.5\x20mg/kg\x20IV\x0a⚠\x20Benzil\x20alkollere\x20karşı\x20allerjisi\x20olanlar.\x20Gebelik\x20ktg:C.\x0aDesferoksamin'},{'ad':'atropin','bilgi':'✦\x20Organofosfat/karbamat\x20toksisitesi,\x20bradikardi\x0a-\x20direkt\x20antikolinerjik\x0a→\x20Organfosfat/karbamat\x20toksisitesi:\x201-6mg\x20\x20IV\x20\x203-5\x20\x20dk\x20da\x20bir,\x20tüm\x20salgılar\x20kuruyana\x20kadar.\x20(yeterli\x20yanıt\x20elde\x20edene\x20kadar\x20çift\x20dozu\x20yapılabilir).\x20Bradikardi:\x20çocuk\x20dozu\x200,02mg/kg\x20IV\x20(maksimum\x20tek\x20doz\x200,5mg,\x201mg\x20maksimum\x20kümülatif\x20doz).\x20Erişkin\x20dozu:\x200,5mg\x20IV,\x203\x20mg\x20kümülatif\x20doz.\x0a⚠\x20Hipertermik\x20hasta,\x20taşidisritmi.\x20Gebelik\x20ktg:C','doz':['0.5mg\x20IV\x20puşe']},{'ad':'atrovent','bilgi':a0_0x555381(0x1b4,'FWQg'),'doz':'1amp\x20atrovent\x20inh'},{'ad':'avil','bilgi':'','doz':'1amp\x20avil\x20100cc\x20SF\x20IV\x20inf'},{'ad':[a0_0x555381(0x17e,'3LX5'),'Metoprolol'],'bilgi':a0_0x555381(0x1b6,'fUk9'),'doz':'1amp\x20(5mg)\x20beloc\x20100cc\x20SF\x20IV\x2015dk\x20inf'},{'ad':'buscopan','bilgi':'','doz':'1amp\x20buscopan\x20100cc\x20SF\x20IV\x20inf'},{'ad':[a0_0x555381(0x18c,'e9AX'),'Enoksaparin'],'bilgi':'✦\x20PE,\x20NSTEMI,\x20unstabil\x20anjina\x0a-\x20antitrombin\x20III\x27e\x20bağlanır\x20ve\x20Faktör\x20Xa\x27yı\x20inhibe\x20eder\x0a→\x201\x20mg/kg\x20Sc\x2012\x20saatte\x20bir\x20veya\x201.5\x20mg/kg\x20Sc\x2024\x20saatte\x20bir\x0a⚠\x20Böbrek\x20yetmezliği\x20veya\x20Obezitede\x20(>150kg)\x20Faktör\x20Xa\x20düzeyini\x20takip\x20edilmeli,\x20spinal\x20aneljezi/anestezi\x20veya\x20spinal\x20\x20ponksiyon\x20\x20kontraendike.\x20\x20Gebelik\x20\x20kategorisi\x20\x20B','doz':[a0_0x555381(0x183,'FxEC'),a0_0x555381(0x1ad,'kbTM')]},{'ad':'combivent','bilgi':'ipratropium\x20bromür\x20monohidrat\x20+\x20salbutamol\x20sülfat\x0a(atrovent\x20+\x20ventolin\x20\x22salbutamol,albuterol\x22)\x0a⚠\x20Taşikardik\x20hastada\x20salbutamol\x20uygun\x20olmaz','doz':'1amp\x20combivent\x20inh'},{'ad':'contramal','bilgi':'100\x20mg\x20/\x202ml\x20ampl\x20tramadol\x20hidroklorür\x20','doz':'1amp\x20contramal\x20100cc\x20SF\x20IV\x20inf'},{'ad':'coraspirin','bilgi':'','doz':'coraspirin\x20300mg\x20PO'},{'ad':['cordarone','Amiodaron'],'bilgi':'✦\x20Nabızsız\x20VF\x20/\x20VT,\x20Geniş\x20kompleks\x20taşiaritmiler\x0a-\x20K\x20akışını\x20bloke\x20eder\x20(Sınıf\x20III\x20antidisritmik);\x20ayrıca\x20Na\x20kanal\x20blokajı\x20(sınıf\x20I),\x20beta\x20blokajı\x20(sınıf\x20II)\x20ve\x20Ca\x20kanal\x20blokajjı\x20(sınıf\x20IV)\x20özelliklerine\x20sahiptir.\x0a→\x20Nabızsız\x20VF/VT:\x20300mg\x20IV\x20puşe,\x20Eğer\x20gerekirse\x20bir\x20sonraki\x20nabız\x20kontrolünde\x20150\x20mg\x20IV\x20puşe.\x20Stabil\x20geniş\x20kompleksli\x20taşikardi:\x20150mg\x20IV\x2010\x20dakikayı\x20takiben\x206\x20saat\x201mg/dakika\x20infüzyon\x20hızında,\x206\x20saatin\x20sonrasında\x200,5mg/dakika/18\x20saat\x20hızında.\x20Max\x20→\x202.2\x20gr/gün.\x0a⚠\x20hipotansiyon\x20yapabilir,\x20prodisritmik.\x20Gebelik\x20ktg:D','doz':a0_0x555381(0x18d,'4q]W')},{'ad':a0_0x555381(0x18b,'3LX5'),'bilgi':a0_0x555381(0x170,'^8H4')},{'ad':['depakin',a0_0x555381(0x17b,'@c1)')],'bilgi':'Migren\x20profilaksisi,\x20bipolar\x20bozukluk\x20ve\x20epilepside,\x20antiepileptik.\x0aYetişkinde\x20başlangıç\x20600mg\x20(idame\x20max\x202500mg).\x20Çocukta\x20başlangıç\x2010-20mg/kg/gün.\x0a\x0aGebelik\x20kategorisi\x20D.\x20Anne\x20sütüne\x20geçer.','doz':a0_0x555381(0x19a,'4UYp')},{'ad':[a0_0x555381(0x180,'FWQg'),'lasix','Furosemid'],'bilgi':a0_0x555381(0x1b3,'iyM7'),'doz':'1amp\x20desal\x20IV\x20puşe'},{'ad':'Desferoksamin','bilgi':a0_0x555381(0x185,'i^^v')},{'ad':[a0_0x555381(0x17f,'3LX5'),'Diazepam'],'bilgi':'✦\x20Nöbeti\x20durdurmak\x20için,\x20yoksunluk(alkol\x20için),\x20ajitasyon,\x20kas\x20spazmı\x0a-\x20GABA\x27nın\x20inhibitör\x20etkisini\x20arttırıyor.\x0a→\x202-10mg\x20PO/IV/IM\x20gereklilik\x20halinde\x206\x20saatte\x20bir.\x0a⚠\x20solunum\x20depresyonu,\x20hipotansiyon.\x20Gebelik\x20ktg:D','doz':'1amp(10mg)\x20diazem\x20100cc\x20SF\x20IV\x20inf'},{'ad':'dicloron','bilgi':'','doz':'1amp\x20dicloron\x20IM'},{'ad':a0_0x555381(0x172,'[jee'),'bilgi':'1\x20steril\x20ampul\x20(2\x20ml)\x200.50\x20mg\x20digoksin'},{'ad':[a0_0x555381(0x18a,'Px9('),'Diltiazem'],'bilgi':'✦\x20Stabil\x20hızlı\x20ventriküler\x20yanıtlı\x20AF,\x20stabil\x20SVT\x0a-\x20Miyokard\x20kasındaki\x20kalsiyum\x20girişini\x20vasküler\x20düz\x20kasa\x20göre\x20daha\x20çok\x20inhibe\x20eder,\x20Av\x20nodal\x20iletinin\x20gecikmesini\x20sağlar.\x0a→\x200,25mg/kg\x20IV,\x2015\x20dk\x20sonra\x200,35mg/kg\x20IV\x20doz\x20tekrarlanabilir.\x20Devam\x20dozu\x205-15mg/saat.\x0a⚠\x20iyatrojenik\x20hipotansiyon,\x20bradikardi,\x20Gebelik\x20ktg:C.\x0aDimenhidrinat','doz':'1amp/25mg\x20diltizem\x20100cc\x20SF\x20IV\x2010dk\x20inf'},{'ad':'Dimenhidrinat','bilgi':a0_0x555381(0x174,'F)zA')},{'ad':'Dobutamin','bilgi':a0_0x555381(0x1a9,'4q]W')},{'ad':a0_0x555381(0x17d,'4q]W'),'bilgi':'✦\x20Dekompanze\x20kalp\x20yetmezliği,\x20hipotansiyon.\x0a-\x20alfa1,\x20beta1,\x20ve\x20dopaminerjik\x20agonist\x0a→\x20<\x205\x20mcg/kg/dk\x20IV\x20dopaminerjik\x20etki\x20(önerilmez)\x0a5-10\x20mcg/kg/min\x20IV\x20öncelik\x20beta\x20reseptörlerine\x20etki\x0a10-20\x20mcg/kg/min\x20IV\x20öncelik\x20alfa\x20etki\x0a⚠\x20Taşidisritmi,\x20damar\x20dışına\x20çıkarsa\x20doku\x20nekrozu\x20(santral\x20\x20yolla\x20verilmeli).\x20Gebelik\x20ktg:\x20C'},{'ad':['dormicum','midozolam'],'bilgi':'','doz':'3mg\x20dormicum\x20IV\x20puşe'},{'ad':'dramamine','bilgi':'Dimenhidrinat','doz':'1amp\x20dramamine\x20100cc\x20SF\x20IV\x20inf'},{'ad':'Droperidol','bilgi':'✦\x20Kusmayı\x20önleme,\x20migreni\x20durdurma\x0a-\x20Dopamin\x20ve\x20alfa\x20adrenarjik\x20reseptör\x20antagonisti\x0a→\x201.25\x202.5mg\x20IV\x204\x20saatte\x20bir\x20ihtiyaç\x20halinde\x0a⚠\x20Nöroleptik\x20maling\x20sendromu,\x20QT\x20uzaması\x20(Torsades),\x20ekstrapramidal\x20yan\x20etki.\x20Gebelik\x20ktg:C\x20'},{'ad':'Epinefrin\x20Adrenalin','bilgi':'✦\x20Anaflaksi,\x20Arrest,\x20Ciddi\x20astım\x0a-\x20alfa\x20ve\x20beta\x20reseptör\x20agonist\x0a→\x20İKYD:\x201\x20mg\x201:10,000\x20IV.\x20Pediatrik\x20İler\x20Yaşam\x20Desteği:\x200.01\x20mg/kg\x201:10,000\x20IV\x20Anaflaksi:\x200.1-0.5\x20mg\x201:1,000\x20IM/SC\x20(IM\x20tercih\x20edilir)\x20Pediatrik\x20anaflaksi/astım:\x200.01\x20mg/kg\x201:1,000\x20IM/SQ\x20(maksimum\x20tek\x20doz\x200.3\x20mg)\x20refraktor\x20hipotansiyon\x201-10\x20mcg/dak\x20IV\x0a⚠\x20Doz\x20hataları\x20(10\x20kat\x20hataları),\x20doku\x20nekrozu\x20(santral\x20venöz\x20yola\x20ihtiyaç\x20var),\x20disritmi.\x20Gebelik\x20ktg:C'},{'ad':['Esmolol',a0_0x555381(0x178,')1AN')],'bilgi':'✦\x20Aort\x20diseksiyonu\x0a-\x20selektif\x20beta1\x20antagonisti\x0aTaşikardi\x20=\x200,5mg/kg\x20(1.dk\x20yükleme),\x200,05mg/kg/dk\x20(4dk’da\x20bir\x20bu\x20oranda\x20artır.\x20max\x200,3mg/kg)\x0aHT\x20=\x2080mg\x20bolus\x0a⚠\x20KKY\x27yi\x20şiddetlendirebilir,\x20hipotansiyon,\x20bronkospazm\x20yapabilir.\x20Gebelik\x20ktg:C','doz':[a0_0x555381(0x1a1,')1AN'),'esmolol\x208cc/st\x20IV\x20inf']},{'ad':'Esomeprazole','bilgi':'✦\x20Üst\x20GIS\x20kanama(varis\x20kanaması\x20hariç)\x0a-\x20Parietal\x20hücrelerdeki\x20hidrojenpotasyum\x20ATPazı\x20inhibe\x20eder\x20(PPI).\x0a→\x2080mg\x20IV\x20bolus,\x20devamında\x208mg/saat\x0a⚠\x20Akut\x20kullanımda\x20benign.\x20Gebelik\x20ktg:B'},{'ad':'Etomidat','bilgi':'✦\x20RSI\x20indüksiyonunda\x0a-\x20Beyin\x20sapı\x20hipnoza\x20sebep\x20olan\x20GABA\x20benzeri\x20etki\x20gösterir\x0a→\x200.3\x20mg/kg\x20IV\x0a⚠\x20Kortizol\x20depresyonu\x20yapabilir(tek\x20uygulama\x20için\x20önemli\x20değil),\x20nöbet\x20eşiğini\x20düşürür.\x0aHipotansiyon\x20yapmadığından\x20buhastalarda\x20tercih\x20edilebilir.\x20Gebelik\x20ktg:C.'},{'ad':['fenitoin','epitoin',a0_0x555381(0x1a5,'Iidg')],'bilgi':a0_0x555381(0x198,'Prje'),'doz':'fenitoin\x201000mg\x20250cc\x20SF/30dk'},{'ad':a0_0x555381(0x18e,'F)zA'),'bilgi':'✦\x20Status\x20epileptikus\x0a-\x20Sdasyon\x20yapar,\x20hipnoz\x20ve\x20anestezi\x0a→\x2020\x20mg/kg\x20IV\x20,\x20tekrarlanabilir\x205-10\x20mg/kg\x20doz\x0a20\x20dakika\x20içinde\x20(max\x20doz\x2030\x20mg/kg);\x20max\x20infüzyon\x20hızı\x2050\x20mg/dak\x0a⚠\x20Hipotansiyon,\x20solunum\x20depresyonu.\x20Gebelik\x20ktg:D'},{'ad':'Fentanil','bilgi':'✦\x20Ağrı\x20kontrolü,\x20Sedasyona\x20yardımcı\x20ajan\x0a-\x20Analjazi\x20sağalayan\x20opoid\x20agonist\x20ile\x20sedasyona\x20yardımcı.\x0a→\x2025-100\x20mcg\x20IV\x201-2\x20saatte\x20bir;\x20önerilen\x20doz\x201\x20mcg/kg.\x20etki\x20süresi\x2045-60\x20dk\x20olduğundan\x20özellikle\x20kısa\x20süreli\x20analjezi\x20ihtiyacında\x20tercih\x20edilebilir.\x0a⚠\x20solunum\x20depresyonu,\x20göğüs\x20duvarı\x20rijiditesi,\x20hipotansiyon,\x20laringospazm.\x20Gebelik\x20ktg:C'},{'ad':'Flumazenil','bilgi':'✦\x20Benzodiazepinlere\x20sekonder\x20solunumu/SSS\x20deprese\x20olan\x20hastalar\x20için\x0a-\x20Benzodiazepin\x20reseptör\x20antagonisti.\x0a→\x200,2mg\x20ilk\x20doz,\x20daha\x20sonra\x20bilinç\x20açılana\x20kadar\x20dakikada\x20bir\x200,2mg\x20verilebilir.\x20Max\x20doz\x201mg.\x0a⚠\x20Epileptik\x20hastalar,\x20nöbet\x20eşiğini\x20düşürür.\x20Gebelik\x20ktg:C'},{'ad':a0_0x555381(0x1af,'Q8s)'),'bilgi':'✦\x20Toksik\x20alkol\x20toksikasyonu\x0a-\x20Alkol\x20dehidrogenazı\x20inhibe\x20eder.\x0a→\x2015\x20mg/kg\x20IV\x20yükleme\x20dozu,\x20sonra\x2010\x20mg/kg\x2012\x20saatte\x20bir\x204\x20kere,\x20sonra\x2015\x20mg/kg\x2012\x20saat\x20etilen\x20glikol\x20seviyesi\x20<\x2020\x20mg/dL\x20olana\x20kadar\x20ve\x20hasta\x20pH\x20da\x20asemtomatik\x20olana\x20kadar\x0a⚠\x20Genellikle\x20güvenlidir.\x20Gebelik\x20ktg:C'},{'ad':'Fosfenitoin','bilgi':'✦\x20Status\x20epileptikus\x0a-\x20voltaja\x20bağımlı\x20nöronal\x20Na\x20kanalları\x20nöbet\x20aktivitesini\x20durdurmak\x20için\x20stabilize\x20eder.\x0a→\x2015-20mg/kg\x20IV\x20yükleme\x20dozu\x20150mg/dk\x20dan\x20uygulanır.\x0a⚠\x20Hızlı\x20uygulama\x20hipotansiyona\x20veya\x20disritmilere\x20neden\x20olabilir,\x20monitörize\x20verilir.\x20Yine\x20\x20de\x20fenitoine\x20kıyasla\x20daha\x20hızlı\x20verilebilmesi\x20avantajdır.\x20Gebelik\x20ktg:D'},{'ad':'Glukagon','bilgi':'✦\x20beta\x20bloker\x20toksititesi,\x20Ca\x20kanal\x20blokerleri\x20toksisitesi,\x20hipoglisemi\x0a-\x20Beta\x20reseptörden\x20bağımsız\x20olarak\x20cAMP\x20üretimini\x20uyararak\x20glukoneogenezi\x20ve\x20glikojenolize\x20artırır.\x0a→\x20Beta-bloker/Ca\x20kanal\x20bloker\x20toksititesi\x20:\x203-10\x20mg\x20IV\x20yükleme\x20dozu,\x20sonra\x201-10\x20mg/saat\x20IV\x20infüzyon\x20dozu\x20Hipoglisemi:\x201\x20mg\x20IV/SQ/IM\x0a⚠\x20Anaflaktoid\x20reaksiyon,\x20hipotansiyon,\x20kusma.\x20Gebelik\x20ktg:B'},{'ad':a0_0x555381(0x189,'l4xl'),'bilgi':a0_0x555381(0x16c,'t0jx')},{'ad':'Heparin','bilgi':'✦\x20Tromboembolizm,\x20AKS.\x0a-\x20Antitrombin\x20III’e\x20bağlanır\x20dolayısıyla\x20trombin\x20ve\x20Faktör\x20IX,\x20Xa,\x20XI,\x20XII\x20inaktive\x20ederek\x20fibronejen\x20fibrin\x20oluşumunu\x20önler.\x20Diğer\x20pıhtılaşma\x20faktörleri\x20üzerinden\x20de\x20etkiler.\x0a→\x20Venöz\x20tromboembolizm:\x2080\x20units/kg\x20IV\x20x\x201,\x20sonra\x2018\x20ünit/kg/saat\x20AKS\x20veya\x20Afib:\x2060\x20units/kg\x20IV\x20x\x201,\x20sonra\x2012\x20ünit/kg/saat\x0a⚠\x20Kanama\x20(etkilerini\x20geçirmek\x20için\x20protamin\x20verilebilir),\x20Dozlama\x20hatası.\x20Gebelik\x20ktg:C'},{'ad':'Hidrokortizon','bilgi':'✦\x20Akut\x20adrenal\x20yetmezlik,\x20Status\x20astmatikus,\x20vazopressör\x20refrakter\x20septik\x20şok\x0a-\x20Birden\x20çok\x20glukokortikoid\x20ve\x20minerelokortikoid\x20etkiler\x20mevcut.\x0a→\x20Akut\x20adrenal\x20yetmezlik,:\x20100mg\x20IV\x20bolus,\x20sonra\x2050\x20mg\x20IV\x206\x20saatte\x20bir.\x20Septik\x20şok:\x2050\x20mg\x20IV\x206\x20saatte\x20bir.\x20Status\x20astımatikus:\x201-2\x20mg/kg\x20IV\x206\x20saatte\x20bir.\x0a⚠\x20immünsüpresyon,\x20hiperglisemi.\x20Gebelik\x20ktg:C'},{'ad':'Hidromorfon','bilgi':'✦\x20Analjezi\x0a-\x20Analjezi\x20sağlayan\x20opoid\x20agonist\x20etki\x20ile\x20sedasyona\x20yardımcı.\x0a→\x201-2\x20mg\x20IV\x203-6\x20saatte\x20bir\x0a⚠\x20Solunum\x20depresyonu,\x20hipotansiyon.\x20Gebelik\x20ktg:C'},{'ad':'K-vit','bilgi':''},{'ad':'Kalsiyum\x20Glukonat','bilgi':'✦\x20Hiperkalemi,\x20disritminin\x20eşlik\x20ettiği\x20hipokalsemi\x0a-\x20Serum\x20kalsiyumunu\x20arttırır,\x20kardiyak\x20miyositleri\x20stabilize\x20eder.\x0a→\x20%10\x20luk\x20çözeltide\x2010\x20mL\x20de\x201\x20gr\x20(kalsiyum\x20veya\x20klorid)\x20içerir.\x0a⚠\x20Disritmi,\x20tetani,\x20kalsiyum\x20klorid,\x20kalsiyum\x20glukonata\x20göre\x203\x20kat\x20daha\x20potent.\x20(\x20kalsiyum\x20klorür\x20periferik\x20damarlada\x20ciddi\x20flebit\x20yapabilir)\x20Gebelik\x20ktg:C'},{'ad':'kapril','bilgi':'','doz':'25mg\x20kapril\x20dil\x20altı'},{'ad':[a0_0x555381(0x1b5,'FxEC'),'Levetirasetam'],'bilgi':'KEPPRA\x20500\x20mg\x20/\x205\x20ml\x20konsantre\x20infüzyon\x20çözelti\x20içeren\x20flakon\x0aHer\x20bir\x20ml’\x20de\x20Levetirasetam\x20100\x20mg\x20','doz':'keppra\x201500mg\x20250cc\x20SF/1st'},{'ad':'Ketamin','bilgi':'✦\x20Aneljezi,\x20sedasyon,\x20RSI\x20indüksiyonunda\x0a-\x20Korteks\x20ve\x20limbik\x20sistem\x20üzerine\x20etki\x20eder,\x20NMDA\x20reseptör\x20antagonisti\x0a→\x20Subdissosiyatif:\x200.1-0.5\x20mg\x20/\x20kg\x20IV.\x20Prosedürel\x20sedasyon:\x200.5-1\x20mg\x20/\x20kg\x20IV.\x20RSI\x20indüksiyon:\x201-2\x20mg\x20/\x20kg\x20IV\x0a⚠\x20laringospazm,\x20(benzodiazepinler\x20ve\x20barbituratlarla\x20tedavi\x20edin),\x20hipertansiyon,\x20taşikardi.\x20(Kafa\x20içi\x20basınç\x20artışı\x20yaptığı\x20görüşü\x20son\x20çalışmalarla\x20artık\x20destek\x20görmemektedir.\x20Kafa\x20travmalı\x20hastalarda\x0ada\x20uygulanabileceği\x20son\x20derlemelerde\x20belirtilmektedir).\x0aGebelik\x20ktg:D'},{'ad':'krs.insülin','bilgi':'','doz':'10U\x20krs.insülin\x20IV\x20puşe'},{'ad':'Labetalol','bilgi':a0_0x555381(0x1b0,'46dk')},{'ad':'Lidokain','bilgi':a0_0x555381(0x17c,'fUk9')},{'ad':'Lorazepam','bilgi':a0_0x555381(0x1a7,'^rGF')},{'ad':'Magnezyum\x20Sülfat','bilgi':'✦\x20Torsad,\x20ventriküler\x20disritmi,\x20eklamsi,\x20status\x20astmatikus\x0a-\x20Fizyolojik\x20süreçlere\x20katılır\x0a→\x20Eklampsi:\x202-4\x20gram\x20IV\x205\x20dakika\x20boyunca.\x20Torsades:\x202\x20gram\x20IV\x20puşe.\x20Astım\x20alevlenmesi:\x202\x20gram\x2015\x20dakika\x20boyunca.\x0a⚠\x20Solunum\x20depresyonu,\x20hipotansiyon.\x20Gebelik\x20ktg:A'},{'ad':'Mannitol','bilgi':'✦\x20Artmış\x20kafa\x20içi\x20basıncı,\x20herniasyona\x20gidiş\x0a-\x20osmotik\x20diüretik\x0a→\x201\x20gram/kg\x20IV\x0a⚠\x20dehidratasyona\x20neden\x20olabilir.'},{'ad':a0_0x555381(0x1a2,'[jee'),'bilgi':'✦\x20Ciddi\x20astım,\x20akut\x20hipersensitivite\x20reaksiyonu,\x20Artmış\x20A-a\x20gradiyentli\x20veya\x0aPaO2:<70mmHg’\x20li\x20Pneumocystis\x20pnömonisi\x20(PCP\x20PNA)\x0a-\x20multiple\x20glukokortikoid\x20ve\x20minerolokortikoid\x20etkili\x0a→\x20Astım:\x201\x20mg\x20/\x20kg\x20IV.\x20Hipersensitivite\x20reaksiyonu:\x201\x20mg\x20/\x20kg\x20IV.\x20PCP\x20PNA:\x2030\x20mg\x20IV\x20x\x205\x20gün.\x0a⚠\x20İmmünsüpresyon,\x20hiperglisemi.\x20Gebelik\x20ktg:C'},{'ad':'Metoheksital','bilgi':'✦\x20prosedural\x20sedasyon\x0a-\x20kortikal\x20ve\x20serebellar\x20sedayon\x20yapar,\x20hipnoz\x0a→\x201mg/kg\x20IV,\x20sonra\x200.5\x20mg/kg\x20her\x202-5\x20dakikada\x20bir\x0a⚠\x20laringospazm,\x20solunum\x20depresyonu,\x20hipotansiyon.\x20Gebelik\x20ktg:B'},{'ad':[a0_0x555381(0x175,'y5*4'),'Metoklopramid'],'bilgi':'✦\x20Bulantı\x20tedavisinde\x0a-\x20Dopamin\x20reseptörlerini\x20antagonize\x20eder\x0a→\x2010\x20mg\x20IV\x206\x20saatte\x20bir\x0a⚠\x20tardif\x20disknezi,\x20ekstraprimidal\x20sendromlar,\x20distoni,\x20methemoglebinemi.\x20Gebelik\x20ktg:B','doz':'1amp\x20metpamid\x20100cc\x20SF\x20IV\x20inf'},{'ad':'Midazolam','bilgi':'✦\x20Nöbeti\x20durdurmak,\x20prosedural\x20sedasyon,\x20ventilatör\x20sedasyon,\x20RSI\x0a-\x20GABA\x20inhibe\x20edici\x20etkilerini\x20arttırmaktadır.\x0a→\x20RSI\x20indüksiyon:\x200.1\x20mg\x20/\x20kg\x20IV\x0aSürekli\x20infüzyon:\x201-10\x20mg\x20/\x20saat\x0aProsedürel\x20Sedasyon:\x200,02-0,04\x20mg\x20/\x20kg\x20IV\x0a⚠\x20solunum\x20depresyonu,\x20hipotansiyon.\x20Gebelik\x20ktg:D\x20'},{'ad':'Morfin\x20Sülfat','bilgi':'✦\x20Ağrı\x20kontrolü\x0a-\x20Analjezi\x20sağlayan\x20opoid\x20agonist\x20ile\x20sedasyona\x20yardımcı\x0a→\x20:\x202-10\x20mg\x20IV\x202-6\x20saatte\x20bir;\x20önerilen\x20doz\x200.1\x20mg/kg\x20IV\x0a⚠\x20Solunum\x20depresyonu,\x20hipotansiyon.\x20Gebelik\x20ktg:C'},{'ad':'muscoril','bilgi':a0_0x555381(0x1a4,'3LX5'),'doz':a0_0x555381(0x1b2,'fD6m')},{'ad':['NaHCO3','Sodyum\x20Bikarbonat'],'bilgi':'✦\x20Hiperkalemi,\x20TCA\x20toksisitesi,\x20salisilat\x20toksititesi,\x20metabolik\x20asidoz.\x0a-\x20Serum\x20bikarbonatını\x20arttırır\x0a-\x201\x20ampul\x2010\x20ml\x20%8.4\x27lük\x20sodyum\x20bikarbonat\x2010\x20mEq\x20(10\x20mmol)\x20sodyum\x20bikarbonat\x20içerir.\x0a→\x20Hiperkalmi\x20veya\x20metabolik\x20asi→\x2050\x20mEq\x20IV\x20x\x201\x0aTCA\x20toksisitesi:\x201-2\x20mEq/kg\x20IV\x20bolus\x20pH\x207.45-7.55\x20arasında\x20tutacak\x20şekilde.\x0aSalisilat\x20toksisitesi:\x203\x20amp\x20(150mEq)\x201\x20litre\x20D5W\x20içinde\x20ilk\x20başta\x2010-20\x20ml/kg\x20bolus,\x20sonra\x202-3ml/kg/saat;\x20hedef\x20idrar\x20pH\x207.5-8.0\x0a⚠\x20KKY,\x20metabolik\x20alkaloza,\x20hipernatremi.\x20Gebelik\x20ktg:C','doz':'10amp\x20NaHCO3\x20IV\x20puşe'},{'ad':'Nalokson','bilgi':a0_0x555381(0x19f,'fD6m')},{'ad':a0_0x555381(0x181,'YROX'),'bilgi':a0_0x555381(0x177,'FxEC')},{'ad':'Nitroprusid','bilgi':'✦\x20Hipertansif\x20acil\x0a-\x20direkt\x20vazodilatatör,\x20NO\x20serbestler\x0a→\x200.3\x20mcg/kg/dak\x20IV\x20başlanır\x2010\x20mcg/kg/dak\x20kadar\x20titre\x20edilir.\x20Maksimum\x20dozdan\x2010\x20dakika\x20sonra\x20kan\x20basıncı\x20hala\x20kontrol\x20altına\x20alınamadıysa\x20nitroprusid\x20kesilir.\x0a⚠\x20siyanid\x20toksisitesi,\x20hipotansiyon,\x20methemoglobinemi.\x20Gebelik\x20ktg:C'},{'ad':'Norepinefrin','bilgi':'✦\x20Sıvı\x20tedavisine\x20yanıtsız\x20hipotansiyon\x20(Şok\x20tablosu).\x0a-\x20alfa1\x20agonist\x20>\x20beta1\x20agonist\x0a→\x201-30\x20mcg/dak\x20IV\x0a⚠\x20taşidisritmi,\x20doku\x20nekrozu.\x0aGebelik\x20ktg:C'},{'ad':'Oktreotid','bilgi':'✦\x20Özefagus\x20varis\x20kanaması,\x20sülfünilüre\x20aşırı\x20dozu\x0a-\x20Damarları\x20vazokonstraksiyona\x20uğratır\x20(özellike\x20GI),\x20portal\x20damar\x20basıncını\x20düşürür.\x0a→\x20Özefagus\x20varis\x20kanaması:\x2050\x20mcg\x20IV\x20bolus,\x20sonra\x2050\x20mcg/saat\x20IV.\x20Sülfonilüre\x20tosisitesi:\x2050\x20mcg\x20SC\x206\x20saatte\x20bir\x0a⚠\x20Safra\x20kesesi\x20hastalıklarını\x20arttırır.\x20Gebelik\x20kategorsi\x20B'},{'ad':a0_0x555381(0x19b,'kbTM'),'bilgi':'✦\x20ajitasyon,\x20psikoz\x0a-\x20dopamin,\x20alfa\x201,\x20histamin\x20ve\x205HT2\x20reseptörlerini\x20antagonize\x20eder.\x0a→\x20:\x205-10mg\x20IM\x20(maksimum\x2030mg/gün)\x0a⚠\x20:\x20Demansa\x20bağlı\x20pskioz,\x20QT\x20uzaması,\x20Nöroleptik\x20maling\x20sendromu,\x20ektrapiramidal\x20yan\x20etki,\x20ortostatik\x20hipotansiyon,\x20IV\x20verilmemesi.\x20Gebelik\x20ktg:C'},{'ad':a0_0x555381(0x1a3,'^rGF'),'bilgi':a0_0x555381(0x19d,'F)zA')},{'ad':'pantpas','bilgi':'','doz':'1amp\x20pantpas\x20IV\x20puşe\x22'},{'ad':'parol','bilgi':'','doz':'1\x20flk\x20parol\x20IV\x2015dk\x20inf'},{'ad':'perlinganit','bilgi':'1\x20ampul\x20Perlinganitte®\x2010\x20mgr\x20gliserol\x20trinitrat\x20vardır.\x20İlacın\x20hazırlanışı\x20şu\x20şekildedir:\x20%\x200.9\x20NaCl\x20veya\x20%5\x20dekstroz\x20solusyonunda\x20çözülebilir.','doz':['1mp\x20perlinganit\x20100cc\x20SF:\x204cc\x20puşe,\x205cc/st\x20IV\x20inf']},{'ad':a0_0x555381(0x1ab,'0Zv5'),'bilgi':a0_0x555381(0x195,'1!F@')},{'ad':['plavix','Klopidogrel'],'bilgi':'✦\x20AKS\x0a-\x20Trombosit\x20aktivasyonunu\x20engellemek\x20için\x20ADP\x20reseptörüne\x20irreversible\x20bağlanır.\x0a→\x2075-600\x20mg\x20PO\x0a⚠\x20Aktif\x20kanama,\x20alerjik\x20reaksiyonlar.\x20Gebelik\x20ktg:B.'},{'ad':'Pralidoksim\x20(PAM)','bilgi':'✦\x20antikolinesteraz\x20etkinliğe\x20sahip\x20olan\x20ajanlarla\x20zehirlenmelerde\x20(Organofosfat\x20intoksikasyonu).\x0a-\x20Kolinesterazı\x20yeniden\x20aktive\x20eder.\x0a→\x201-2\x20g\x20100\x20SF\x20içinde\x2015-30\x20dk\x0a⚠\x20Allerji.\x20Gebelik\x20ktg:C'},{'ad':'Prednizon','bilgi':'✦\x20Astım\x20atak,\x20alerjik\x20reaksiyonlar,\x20A-a\x20gradiyent\x20>35\x20veya\x20PaO2:<70mmHg’li\x20Pneumocystis\x20pnömonisi\x20(PCP\x20PNA)\x0a-\x20Çeşitli\x20glukokortikoid\x20ve\x20mineralokortikoid\x20etkiler\x20üretir.\x0a→\x201mg/kg/gün\x20PO\x0a⚠\x20İmmünsüpresyon,\x20GI\x20ülser/perforasyon,\x20hiperglisemi.\x20Gebelik\x20ktg:C'},{'ad':'prednol','bilgi':'250mg\x20metilprednizolon\x20içerir','doz':a0_0x555381(0x176,'J&Gp')},{'ad':'Propofol','bilgi':'✦\x20prosedürel\x20sedasyon,\x20ventilatör\x20sedasyon,\x20RSI\x0a-\x20GABAa\x20agonisti,\x20Na\x20kanal\x20blokörü\x0a→\x20Prosedürel\x20Sedasyon:\x201\x20mg/kg\x20IV\x20bolus\x20sonra\x0a0.5\x20mg/kg\x20\x203\x20dakika\x20bir\x0aRSI\x20indüksiyonun:\x201.5-2.5\x20mg/kg\x20IV\x0aVentilator\x20Sedasyon:\x205-50\x20mcg/kg/dak\x0a⚠\x20hipotansiyon,\x20anaflaksi,\x20Bradikardi,\x20apne.\x20Gebelik\x20ktg:B'},{'ad':'Protamin\x20sülfat','bilgi':a0_0x555381(0x19c,'fUk9')},{'ad':'pulmicort','bilgi':'etken\x20maddesi\x20budesonid','doz':'1amp\x20pulmicort\x20inh'},{'ad':'Ranitidin','bilgi':'✦\x20Aktif\x20ülser\x0a-\x20histamin\x20H2-reseptör\x20antagonisti\x0a→\x20150\x20-300\x20mg\x0a⚠\x20Allerji.\x20Gebelik\x20ktg:B'},{'ad':'Regüler\x20İnsülin','bilgi':'✦\x20Hiperkalemi,\x20DKA/Hiperglisemik\x20hiperosmalar\x20koma,\x20Kalsiyum\x20kanal\x20bloker\x20toksikasyonu\x0a-\x20Periferik\x20glukoz\x20alımını\x20arttırır,\x20potasyumu\x20intraselüler\x20alana\x20çeker,\x0a→\x0aHiperkalemi:\x205-10\x20unit\x20IV\x20x\x201.\x20DKA’da\x200.05-0.1ü/kg/saat\x0ainfüzyon.\x0aKKB\x20toksikasyonu:\x20Eğer\x20kan\x20şekeri\x20<250\x20mg/dL\x20ise\x2025\x20gram\x20dekstroz\x20ile\x20birlikte\x201\x20unit/kg\x20bolus\x20verilir;\x20Kan\x20şekerini\x20100200\x20mg/dL\x20arasında\x20tutacak\x20şekilde\x200.1\x20-1\x20ü/kg/saatten\x20dekstroz\x20ile\x20titre\x20edilir.\x0a⚠\x20hipokalemi,\x20hipoglisemi,\x20sadece\x20IV\x20yoldan\x20verilebilir.\x20Gebelik\x20ktg:B'},{'ad':'Rokuronyum','bilgi':'✦\x20Paralizan\x20olarak\x20RSI\x0a-\x20non-depolarizan\x20nöromüsküler\x20ajan\x0a→\x201mg/kg\x20IV\x0a⚠\x20uzamış\x20paralizi.\x20Gebelik\x20ktg:B'},{'ad':'Süksinilkolin','bilgi':'✦\x20RSI\x20paralize\x0a-\x20depolarizan\x20nöromüsküler\x20ajan\x0a→\x201.5\x20mg/kg\x20(veya\x203-4\x20mg/kg\x20IM)\x0a⚠\x20hiperkalemi,\x20hiperkalemi\x20ile\x20birlikte\x20subakut\x20yanık/ezilme,\x20glokom,\x20kafa\x20içi\x20basıncını\x20artırır.\x20Gebelik\x20ktg:C'},{'ad':[a0_0x555381(0x16f,'#kDM'),a0_0x555381(0x179,'@c1)')],'bilgi':'TEOBAG\x20®\x20200\x20SOLÜSYON\x20200mg/100ml.\x20TEOBAG\x20®\x20400\x20SOLÜSYON\x20400mg/500ml.\x0aBronkodilatatör.\x20Genelde\x20diğer\x20ted.yanıtsız\x20hast.tercih\x20edilir.\x0aYetişkinde\x202x200-300mg.\x0a6\x20yaşından\x20büyük\x20çocuklarda:\x20Önerilen\x20doz\x202\x20x100-200\x20mg.\x0aGebelik\x20kategorisi\x20C.\x20Anne\x20sütüne\x20geçer.\x0a⚠\x20Kontrendikasyon;\x20aktif\x20peptik\x20ülser,\x20aşırı\x20duyarlılık.','doz':a0_0x555381(0x187,'Q8s)')},{'ad':'tetanoz','bilgi':'','doz':['tetanoz\x200','5cc\x20IM','1\x20doz\x20tetanoz\x20aşısı\x20IM']},{'ad':a0_0x555381(0x1aa,'FWQg'),'bilgi':a0_0x555381(0x18f,'cxJ^')},{'ad':'Tiyopental','bilgi':a0_0x555381(0x1a0,'F)zA')},{'ad':'transamin','bilgi':'Her\x20ampul\x20250\x20mg\x20traneksamikasit\x20içermelidir.','doz':'1gr\x20(4amp)\x20transamin\x20100cc\x20SF/10dk\x20IV\x20inf'},{'ad':['ventolin',a0_0x555381(0x1ac,'3LX5'),'Albuterol'],'bilgi':'✦\x20Akut\x20bronkospazm,\x20hiperkalemi\x0a-\x20Selektif\x20beta\x202\x20agonisti\x0a→\x201\x20saat\x20içinde\x202,5-5mg\x2020\x20dakikada\x20bir.\x20Sonra\x20her\x201-4\x20saatte\x202,5-10\x20mg\x0a⚠\x20Taşikardi,\x20hiperglisemi,\x20hipokalemi.\x20Taşikardide\x20atrovent\x20tercih\x20et.\x20Gebelik\x20ktg:\x20C','doz':'1amp\x20ventolin\x20inh'},{'ad':'Verapamil','bilgi':a0_0x555381(0x173,'iyM7')},{'ad':['zofran',a0_0x555381(0x196,')1AN')],'bilgi':'✦\x20Bulantı\x20ve\x20kusma\x0a-\x20seratonin\x205-HT3\x20reseptörlerini\x20antagonize\x20eder,\x20\x20santral\x20etkili\x20antiemetik\x0a→\x204-8\x20mg\x20IV,\x204-6\x20saatte\x20bir,\x201amp\x204\x20mg\x0a⚠\x20torsad,\x20QT\x20uzaması,\x20Gebelik\x20ktg:B','doz':'1amp\x20zofran\x20IV\x20puşe'}];function a0_0x33d9(){const _0x10190f=['WOVcJmkgWQNdRW','cK3dMc14tguCgui5gte','futdISkNALxcPG','egipcJfZACoBW5ZdSKuiWOdcS8ki','fh0kw2jHz8ooW5RdMuaP','4P2UDCkbW4ZcR8oEqv7cLSoDWOJdQbfuW4KQW7hdKbdcVCkrr0tcQ8kzW7O4WOVcImk5W5BdTGTFWOjFsmk8W6BcHdVdTmkNW6xcN8kZX79eW5j/W4JcN8kpWR3cJCobxCkgkmkVWPPOaNRdLSoqE8ovbvRcL1WGWRVdV8kKfmo24OwHWRhdGeJcH8oDW47cRNCLWPFdV0/dNaxdLNnQbw1DW7i/WRtdSCoUoIVcJCkWtSk9rmoGW5HXrWrLzxZdJXL34PQYdSoRWQ3dGSoSxH9uW6jqWOBdGSolW4hcTuDhWRPNBSotWQxhGqVdV8kEB8kSDuRdHYHaW60bquZcG8o7W5FcLcJdHSoDW5rO','yx0HW6xcUvhdP8k2CmkmwmkQW6ddJq','DmoBCWFdPqBdKCkZW6VdOCoOWPuIEf7cLmojpCklW5JcGCkFWOxcPCosza','WPawe8oztMrp','pWnKWQ7cQSkfWRv3aCo1WQW','suxdJmkCBMFcUw0','nc55WR7dUbi','WQz+WP8edColW4G','WQ7dSCk/W740z8o3pSknWPNdGCoMxtOGW5VcIvCMpSoCXQ9m','vv8cCmkNW57cM8owW6CFjCkl','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','W4/dGGy','W4FdQ8kEWRHFW4/dVtzfW5/dK8ojieJdVmkczeSc','xtlcKCo7k8oLcuy','iSkSW4BcMvpcTfaNpgTOb8kIWP8ltSkqW6ToXi1t','cSo5l8kqf3X7','4PY5W75fWQP4FSoBcmkIdx7cMJtcM1DTWO/cQmkfdeldRCkTxdZcReFdPxlcHIjptMy+EuO8WO02e8oDdmoP4OwuWPKudIJcVHfRW4Pvc1mQW4KyW4vCemkBW4hdKSoPWPRcJ03dUCkdW5PXgokyHGVdUq7cR8k0WQVdJWxdGmkEsmo6W6/cTSoyWQldLwT9W7b+W6tcQGXaW40LW488W6TjW4pcNqi','uM4YW4uyW50egciOWOW','WQHmWP4PwSoE','nCoJWQRdRCoQECk9B8kQWPXeb8kpaCkmmmkLrSoouCoCDCoeW5L+aCkQ','jmkemGi','zSoPu8k1pCoKW4zTDX84eColB1NcQ8o9WPvLBCoAW6uHzSoBFmkcW4q','jSo6imknaNfUWQ7cJW','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','4PY1gIVdICkxWPpdICoXW7WepSkoW4xdJmoov8koW7JcLhxcQHBcJ8o2gqKVW4iiWOHSWQWuWP0GcSodWP7dUf3dRHfpWPldG8kMWOOtW4NcUuBfQg5rWQyGmCkXbCoWxCkBz21HDCklWP1Aw8kJBbNdQmoAfcfzWOPmbKa/xmkrW7JcIh/IHyJdQWJcT8kuECkYWQpcL8k14PQFWQ5KW7xdRCkVWPRdINdcM8kTWQxdTSkIzsFdJYCicSklh8oAW4ef','W57dNmonW7hcT8kDmdldSmklWPWiya','4P2/WOBdIKleM8ouW53dSCo7WPZcTSk5oSoGWOfTW7yrWOJcSq1hncddQ8kaBSoMCmkyxdtcMWTsW7tdGmkjWQhcGmk0CrOyxZBcOIpdVf7cQHBcLeRcU8kjWR1hW449DvqUW7VdJSozb39JwetcT2fUW7OnBmoGWRqSkHRcINFcTMTAW4bkgmozECoThtNdV8k0EwaWWP/cOEkhLdFdTSk9xSkKeutdOXm1WQNdKSkXvJ4K4PQGW5VcP1tdU8oAzCoKiCosoh8IFYezW7KjqgZdMCkBWRy3','4PY1gJ5mWOZcTCoeWPtdIsOgWQBIGRRcGSsjq8olW6ZcKgZcPHldLYaXcIBdNaJcIg/cRaJdUc0FW5JhNmo7xSkVyKlhJCoDX6xcI8wpW4xdOgaUxmsUWQeGk8EHgSk/xEkePgCiiZFdImohfdBcLcm9W47cM00PqCkdXBPewt7hTCkgdUkyHLxcM8k4smA2WPqYWRlcKSkZW4PlWQ5mW7FdTCkVWPRdJxddGCoSWOZcS8kWBZNdGcvAcmotwmooW4rovJJcIuO6W6ddG8kxjrvP','Ehm7W4SAW4entgqKWOhcPmk8W5RdULRcKdxfVq8','W7JcR1xcOSo3hGGGW5NdGCoumXtdNCkRaq','WO5aWQ/cISkCWQe8WRtcP3WW','yMT/WP3cRqRcTSoPbmkCECkQW6hdKZS2z2f4FfipDSouevVdG8owW711svygW4S8WOZcICkck8kAh8wobXvkhLlcPCoeWODwWOufe1W','e8khW67cHvhdQeikoG','WOhcV8oyW7qzWPlcR05QW43dK8oG','4P+4aCkfWPVcN8k4pmkSWQH+FmkiFcSDWQLLWP3cNmkwWQldOCkjWPVcKSo2WQilxmokWPBdKgNdKCkhDthcQCknw0hcUfxcI1OVW4rItK9egCk7xSo3WQlcQCoVfSkvnSkPteawyI7cOeORWPSOWO0bW7f14OcOvmwtD3elWOZdUmoMDXToaSoSECoIuCoLW5ZdKddcNCo6h8kiwL3fHmoVXOlcOqddPUkeSu3cPmk5WPu6d8kcfflIH7xcM8ozg8k2btxdRSkbW4pdQmErcConkeZdHthcT8kUqmkHjCkBW6tdQ8o/mCk9W6fzWR7dUL3dJCo/W5NcKmkt4PQHW4SWWPrbWQVdUIhdRamgWQRcOCkEWQLLyLNcR8koWPRdLIjuW7KnvaNcK1hdGe3cT8k/BCoamSoFWP7cG0fcW7KnW5GxWQJdJCk8','W7CLW49ovCkvW6RcQ8kxuqnX','4P67W6hdI8o2ocJdUshcNSktW5RdSri/jmkxWRaHFYVdNCkDtmkVW6NcOCAVW6mACM/dT8ouW60dedOfDIXSwSkkquCFWP8okCkeBCoeW6Prncn6W4zhnLPeeZ/cIX7dVhWTrflcO8kJW6/cSuXXbmkDWQGzW6aQW4tcGeqdmokeSHupWQBdOerWWPJcSmoZW5eqW4yAWPnDW4y0W5xcJCk24PUyWPySBSAvtha5WQzBbYfGWQZdPJRdRtqTDSkLW4/dUSkFW4hdM2nvB8k9ySoaFCoRCKpdMG3dU8k6WPlcRNRcJNJdPJb/WPZcOCoDWRWYW54xW4BdLSkrWOueD8oobSo3Bh7dPJ1bW61FbmkNvt7dVmkDW4BdICoWW4TDW7xdTd9gWQlcRbjhW5ldJCkyWPmZ','WRVcGmkwWQNdPmoEydZdUSkU','WQmCcCodrwfek8onjetcIq9iDxZcUcf8WQNdUW','iYP+WRpdVXlcVSoVs8kr','wCk6D8kagZb9WQVcHmkwWR7cR8kboJO','ldfLWPvbWPWkpdWVWQddHq','rSorCqddTaJcI8oUWRC','4P+4amkKWQijh8kqafHCW54nWRTQhMRcP8kGWPBdK8oXWQ/dLuP2W4VdP8k5WQKGWOy5W4vTW7DyBIVcScFcJM4dW4SUySokW6DVW5NcNwtcIvxdQEkgSmowfKbZW6pcL1O1a+khQCoHemo2WORcN33dLmk7uZKEdK5OW6XxWRTMc27cUHZcJCkOs8k6qSoWxCkMx1hcJCoKE1CGWQFdM37cPYWKWOK1uWpcMCkXW7RdQgfNWRhcOWNcPmoaxSovWPfkrMzxomkgW55Zgb4es0ddRGxcJSk1D+kzVmkCjCkyuCo5uqHXB8kkW44NomkKa8ofWQz6W70iW4Onv8kSW5NcJblcO8oiWQjfFghdKCowzCkPc8ofWPBdJmoyW4nS','W6KsW7ddImokW6z4WOZcMfq6WO9J','AmohW6nDjmoyW4tcOSoUWPBcVCkXDSkZWQ1o','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','W4ldICkHWQNhNmofBJhdP8k4WRSRdsOaWOVcQIJdT8kRW73cKSoNW7hdKmkEW544WOeQEfNcTCk/nSkqW5pcKKXAWP1dW7RcM8o8EhnSysNdGGy4jCo5b8kAqqlcISoUW61Jjs3dHCknWOVdUtddRSo1WP1zvSk9qZ3dSvmoW5yqdbu3W7Tu4PUOW5iDj2rjeHiPW74ZW4FcGmkCWR5wzmofWPtdTSoQW5nFW5zspH03amoEWPu5WQemW7BcRCkpWPVcIG','sYTlgsaY','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','umkNxH4','4P+eW5WsWRJcGdhdLGJdM8k2zW5KCt7cUvj6W4RcS8onpCkDWR3cL10xE8oKW7xcL2qfj8o+W57cHtZdPmo/W78EtgCmWPZcNSojFSoPCokeM8kBbmkrt3FcJCkxEsnGmYKfWOVdS8orW74oWQa9vCk6C0RdUf9JsCoSkSkcWObJovKgwCk+Xl9bymkkb8o5WOzXW5r/W4P6tqxdSUkBOColxmk0W4upv2hdJSo6W5BdISsuvSAiWPqHW4O8W73cJ8o0F33dQSkhnmogWQJdIK7dOmkmXjdcO8oOWQxcUSopcCkDW7zcWPejxCkLWQJcSYBdRZOsm8oWu2ZcJSoeW4HhW4nmtI0NWPhcLv0KcmoqyctdISkDW7n1W71kW7VcK8o6j8ktrYj6WRNcULSieCkJFCoFW77cU8owW6CqmG','mCkpl1tcS1pcMSorWRFcUCohWRm','WPiaeCoNAG','W40FrCkBcCky','W6mgDcD8W55qW4ddK0hcQ8kkrrNdKCoJW7bXww7cI2eRqYLjW64','wmkInCkig3nxWR0','W5hcO0BcPmoJbXq','4P6oW6pcGSkRW5r8hGzudSkjWQ1SDmoyW5FcNmounISyWPlcIKpdNcpdU8o0W7xdHLVcQGfiWQNcTcrhW5hdNt0TW7uYWOxIHOpcUcpdQH8j4OgPfMiDmSkPhmoJWQyue8kOg8kjW4JdTwzcvtbjySkH4Oodqh3dT8ooW5lcPxdcL3NdSmomWPjzBSox4PMBbSkln8kXWRtcHqTTW4ddSJz2ySo8gCo3WRzVWRFcV3b+p2hcLKxdO8oeh3KYWR7dGXSEWQerWR7cUCkYWQC6W4tcImo7vLLRWQVdHSk1WQlcVfbRWPrPmSoay0LkWRqRs2pdICkDWO7cVhJcVMhcHKTrWO4pzmoXWQBcJftdVmoIwCk2W6KdWRlcKSoFW64jWRyyot14rCoxWODJEJ7cOqW','4PY1gJP6WRFdI8kaW5pdOuDKWOxdLSkawupcN8AVW5vPWQzcW4JcOZaliSkKtmogq8kGfCkSlqVdG8kdWRD7W65ZcSkoW4lcP8kadSkrB3pcPfpcJCoTod7cOSwzX446W5CRXiWZE8krWOzvhmk8Br3dOSoEfc1tWODxsIpIH5NcISownmklrmoQW7SCW6RcNHtIMlldK8kzW5ntW6TxW7pdQmoKW4JdP3ZdL8oOWO7dUSkRicddKISsi8or','vmkStb5wqSoYp8ooWOPsW7e3','W7ddUMm9WQKOqXJdPwiKW59oW6azWQ/cNmoAXBpcRG','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','x3iZW5iFW4WnaZm','WO/dKSkltSktv8o7W7W','es93WR/dPrZcTSoS','WO3dLSkiwmkivmo7W7LIW6ldQ8oeiq','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','W5NcRSo/W7i+lSo6','mI5+WR7dQq','ncjZWQVdRWS'];a0_0x33d9=function(){return _0x10190f;};return a0_0x33d9();}